Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport

J Sims-Mourtada1, J G Izzo, J Ajani

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncogene
|March 14, 2007
PubMed

Insights

Inhibiting the Hedgehog (Hh) pathway enhances chemotherapy effectiveness by reducing multi-drug resistance (MDR) in cancer cells. Hh signaling increases drug efflux via ATP-binding cassette (ABC) transporters, contributing to MDR.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Multi-drug resistance (MDR) is a significant challenge in chemotherapy, often caused by increased drug efflux mediated by ATP-binding cassette (ABC) transporters.
  • The regulation of ABC transporters in cancer and their role in MDR are not fully understood, limiting effective clinical strategies.
  • Constitutive activation of the Hedgehog (Hh) signaling pathway is implicated in the growth and maintenance of various cancers.

Purpose of the Study:

  • To investigate the role of Hedgehog (Hh) signaling in chemoresistance and explore its potential as a therapeutic target.
  • To determine if Hh pathway activation influences the expression and function of ATP-binding cassette (ABC) transporters involved in multi-drug resistance (MDR).

Main Methods:

  • Assessing the impact of Hh signaling inhibition on cancer cell response to various chemotherapies.
  • Investigating the mechanism by which Hh pathway activation induces chemoresistance, focusing on drug efflux and ABC transporter activity.
  • Analyzing the regulation of specific ABC transporters, including MDR1 (ABCB1) and BCRP (ABCG2), by Hh signaling.
  • Utilizing small interfering RNA (siRNA) to knock down MDR1 and BCRP expression and evaluate its effect on Hh-induced chemoresistance.

Main Results:

  • Inhibition of Hh signaling significantly improved cancer cell sensitivity to multiple chemotherapeutic agents.
  • Hedgehog (Hh) pathway activation was found to induce chemoresistance, at least partially, by enhancing drug efflux dependent on ATP-binding cassette (ABC) transporters.
  • Hh signaling was demonstrated to regulate the expression of key ABC transporters, namely multi-drug resistance protein-1 (MDR1, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2).
  • Targeted knockdown of MDR1 and BCRP expression using small interfering RNA (siRNA) partially reversed the chemoresistance induced by Hh pathway activation.

Conclusions:

  • The Hedgehog (Hh) signaling pathway plays a crucial role in mediating chemoresistance in cancer.
  • Hh pathway activation contributes to multi-drug resistance (MDR) by upregulating ATP-binding cassette (ABC) transporters involved in drug efflux.
  • Targeting the Hh pathway presents a promising strategy to overcome MDR and enhance the efficacy of chemotherapy in cancer treatment.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...